For: | Isakov N. Cancer immunotherapy by targeting immune checkpoint receptors. World J Immunol 2018; 8(1): 1-11 [DOI: 10.5411/wji.v8.i1.1] |
---|---|
URL: | https://www.wjgnet.com/2219-2824/full/v8/i1/1.htm |
Number | Citing Articles |
1 |
Fatemeh Bayati, Mahsa Mohammadi, Maryam Valadi, Saeid Jamshidi, Arron Munggela Foma, Ehsan Sharif-Paghaleh. The Therapeutic Potential of Regulatory T Cells: Challenges and Opportunities. Frontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.585819
|
2 |
Laura Lorenzo-Sanz, Purificación Muñoz. Tumor-Infiltrating Immunosuppressive Cells in Cancer-Cell Plasticity, Tumor Progression and Therapy Response. Cancer Microenvironment 2019; 12(2-3): 119 doi: 10.1007/s12307-019-00232-2
|
3 |
Luisa Barrueto, Francheska Caminero, Lindsay Cash, Courtney Makris, Purushottam Lamichhane, Rahul R. Deshmukh. Resistance to Checkpoint Inhibition in Cancer Immunotherapy. Translational Oncology 2020; 13(3): 100738 doi: 10.1016/j.tranon.2019.12.010
|
4 |
Vincent T. Ma, Charles S. Katzman, Phillip L. Palmbos, Rajiv M. Patel, Johann E. Gudjonsson, Ajjai S. Alva. NB-UVB phototherapy in the treatment of anti-PD-1 inhibitor induced psoriasis: A case report. Current Problems in Cancer: Case Reports 2020; 1: 100004 doi: 10.1016/j.cpccr.2020.100004
|